A UK skincare business looking at Korean manufacturing is usually balancing two things: the sector's reputation for formulation and fast product development, and the practical challenge of assessing a supplier from nearly 9,000 kilometres away. Good decisions come less from finding the "best" manufacturer than from finding the right one for a particular product, volume and level of support.
What follows is a structured way to make that assessment. It separates what the law requires from what we suggest as sensible practice, and it points to the official sources you should check yourself.
Who you are actually talking to
At a trade show or in an email thread, three very different kinds of business can present themselves in similar language. Knowing which one you are dealing with changes the questions you ask.
Manufacturers
Korea's Cosmetics Act defines a cosmetic manufacturing business as one that manufactures all or part of a cosmetic product, and it expressly excludes businesses that only carry out secondary packaging or labelling. Manufacturing businesses must register with the Ministry of Food and Drug Safety (MFDS), and the Act sets obligations for records, facilities, equipment and the testing of raw materials and finished products (Cosmetics Act).
Responsible distribution businesses and brand owners
The same Act separately defines a responsible cosmetic distribution business: a business that distributes or sells cosmetics, or supplies them for import, "while controlling the quality, safety, etc." of those products (Cosmetics Act). Many Korean brand owners sit in this category. They may have their own laboratories, or they may commission a manufacturer. A brand owner can be an excellent partner for distributing finished products, but it may not be the right counterpart if you want to develop a product of your own.
Trading companies and agents
Trading companies and sourcing agents often represent several factories. They can be genuinely useful: they may consolidate small orders, handle export paperwork and translate. The trade-off is distance from the production floor. Ask directly whether the business owns or operates the facility, which factory would make your product, and whether you can speak to that factory's quality team.
Ask for the company's registration details and the address where your product would physically be made. If any stage, such as filling or packaging, would be subcontracted, ask where and by whom.
Match specialisation to the product
"Skincare manufacturer" covers a wide range of equipment and expertise. A business that fills large volumes of toner may have little experience with high-oil balms, sun protection, sheet masks or cushion compacts. Specialisation matters because process knowledge, such as emulsifying, handling heat-sensitive ingredients or filling viscous products, rarely shows up in a brochure.
Ask which products in your category the manufacturer currently makes, in which formats and fill sizes, and whether it develops formulas itself or fills to a customer's specification. That last point determines how much development support you will receive and who is likely to own the formula. We explain the differences in OEM, ODM and private-label cosmetics explained.
Korean regulatory categories are also worth understanding, though they do not transfer to the UK. In Korea, certain "functional cosmetics", such as products for whitening, wrinkle improvement or UV protection, must be evaluated by, or reported to, the MFDS before sale (MFDS). A manufacturer with this experience may be comfortable producing supporting data. That status says nothing, however, about what a product may claim in Great Britain.
Communication as a working test
The early email exchange is a free trial of the relationship. Useful signals include a named contact who answers the question you asked, written confirmation of what was agreed, and a willingness to say "we do not know yet" rather than promising everything.
A few habits make cross-border communication more reliable in our view:
- Keep one master product specification and give each revision a version number and date.
- Follow every call with a short written summary of decisions and open points.
- Agree how technical questions will reach the formulation and quality teams, not only the sales contact.
- Allow for the time difference. Korea is eight or nine hours ahead of the UK, depending on British Summer Time, so a question sent in the UK afternoon is usually answered the next morning at the earliest.
What samples can and cannot tell you
Samples are essential, but they answer fewer questions than people hope. A laboratory sample shows texture, colour, fragrance and how the product feels in use. It does not show whether a full production batch will match, whether the formula is stable in its final packaging over months, or whether it meets UK requirements.
When you request samples, clarify whether they come from an existing formula or a new development, whether the manufacturer charges for them, and what batch or formula version each one represents. Keep a simple log of versions, dates and your team's comments. The log becomes valuable when a later sample feels different and you need to know why.
Documentation for the UK market
This is where UK and Korean requirements meet, and it is worth raising before any commercial commitment.
In Great Britain (England, Scotland and Wales), a cosmetic product cannot be placed on the market unless there is a Responsible Person established in the UK. That Responsible Person must ensure a safety assessment is carried out by a suitably qualified assessor, keep a Product Information File, and notify the product through the government's Submit Cosmetic Product Notifications service before it is sold (GOV.UK, GB; OPSS guidance, GB). Northern Ireland follows EU cosmetics rules under the Windsor Framework: the Responsible Person must be established in Northern Ireland or the EU, and notification goes through the EU's portal instead (OPSS guidance, NI).
The Responsible Person holds these obligations, but much of the underlying information comes from the manufacturer. The table below shows typical inputs to discuss.
| Information | Why it matters |
|---|---|
| Full quantitative formula | The safety assessor needs exact ingredients and concentrations. This is often shared directly with the assessor under confidentiality. |
| Raw material specifications and safety data | These support the safety assessment and help confirm the ingredient list. |
| Stability and packaging compatibility data | GB guidance lists physical and chemical characteristics and stability among the information the safety report must consider (OPSS guidance, GB). |
| Microbiological quality and preservation data | These show the product resists contamination in normal use. |
| Good manufacturing practice evidence | Manufacture must follow good manufacturing practice. ISO 22716 is the standard named in UK guidance, though not the only way to demonstrate it (GOV.UK, GB). |
| Certificate of analysis for each batch | This links the product you receive to agreed specifications. |
One detail is often missed. ISO 22716 covers the production, control, storage and shipment of cosmetic products, but the standard itself states that it does not apply to research and development or to the distribution of finished products (ISO). A certificate therefore tells you something useful about a factory's systems. It does not tell you that a particular new formula is safe or compliant.
Capacity, minimums and lead times
Minimum order quantities (MOQs) rarely have a single number. A manufacturer may set a minimum per formula, per product variant and per batch size, while packaging suppliers set their own minimums for bottles, pumps, cartons and printing. Ask how the minimum is calculated and which component actually drives it. Sometimes a stock container lowers the effective minimum more than any negotiation would.
Lead time is similarly made of parts: sourcing raw materials and packaging, waiting for a production slot, manufacturing, quality control release and shipping. Ask which parts the manufacturer controls, how it handles busy periods, and what happens if a batch fails its release tests.
Questions to ask before you commit
- Where exactly will the product be made, filled and packed, and will any step be subcontracted?
- Which products like ours do you make now, and could we see non-confidential examples?
- Will you develop the formula, adapt one of yours, or produce to our formula? Who will own it?
- What stability, compatibility and microbiological testing do you normally perform, and on which packaging?
- What evidence of good manufacturing practice can you share, and when was it last audited?
- How are formula changes and raw material substitutions communicated to customers?
- What is the minimum for this product, and which component sets it?
- Have you supplied products for the UK or EU before, and which documents did those customers request?
Making the decision
When several candidates look plausible, a short written comparison helps. Score each one against the same criteria: product fit, documentation readiness, quality of communication, commercial terms and your confidence in their answers. Weight the criteria according to what matters most for your product.
It is common, and in our view sensible, to begin with a limited first order or a pilot product rather than a full range. A smaller start tests the whole chain, from documentation through production to shipping and your own quality checks, while the cost of learning is still modest. If the relationship works, it can grow from there.
Finally, remember that regulatory responsibility in the UK does not move to the manufacturer because the manufacturer is experienced. Whoever acts as Responsible Person must be satisfied that the product and its file meet the rules for the part of the UK where it is sold.
